Granules India shares in focus on acquiring Swiss firm for Rs 192 cr
Granules India has acquired Swiss CDMO company Senn Chemicals AG for Rs 192 crore, expanding its peptide therapeutics market ...
Granules eyes foray into peptide segment, CDMO business with ₹192 cr. acquisition of ...
Generic drugmaker Granules India is foraying into the peptide segment and contract development and manufacturing organisation ...
AZOM8 天
Optimize the Peptide Synthesis Process with Peptide-ExplorerLT
The Peptide-ExplorerLT ™ is designed for scientists who need to optimize and explore linear peptide synthesis. The product is a high-spec flow chemistry system that uses continuous flow. The product ...
FiercePharma1 天
India’s Granules makes $22M play for Senn Chemicals to enter peptides CDMO business
In a bid to break into the CDMO business at one of its most lucrative angles, India's Granules is snapping up Swiss contract ...
Daily2 天
Granules India enters high growing peptide segment, CDMO business by acquiring Senn Chemicals
Hyderabad: Granules India Limited has announced the signing of the acquisition agreement regarding Senn Chemicals AG, a Swiss ...
Granules India to acquire Senn Chemicals AG for ₹192 crore
Granules India acquires Senn Chemicals AG, expanding into peptide therapeutics and CDMO capabilities for global growth.
Your Story3 天
Granules India acquires Swiss-based Senn Chemicals AG for Rs 192 Cr
With this acquisition, Granules gains capabilities in high-growth peptide-based therapeutics. It also aims to enter the ...